# ImmunoMet Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/immunomet-therapeutics

- Industry: Biotechnology
- Headquarters: Houston, US
- Website: www.immunomet.com
- Total disclosed funding: $10M
- Latest round: Series B (Mar 7, 2017)
- Investors on record: 7

## About

Founded in 2015 and based in Houston, Texas, ImmunoMet Therapeutics, Inc. operates as a biopharmaceutical company, developing anti-tumor and immuno-oncology therapies.

## Funding rounds

- Series B, Mar 7, 2017, $5M — InterVest, SL Investment, NHN Investment, Mirae Asset Venture Investment, GNTech
- Series A, Mar 8, 2016, $5.2M — Mirae Asset Venture Investment, MetaVest, Aju Tech, GNTech

## Investors

- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series A, Series B
- MetaVest — Series A
- Aju Tech — Series A
- GNTech — Series A, Series B
- InterVest (https://capitalatlas.ai/funds/intervest) — Series B
- SL Investment (https://capitalatlas.ai/funds/sl-investment) — Series B
- NHN Investment (https://capitalatlas.ai/funds/nhn-investment) — Series B